Page 11 - Pharma Analyst News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Takeda continues collaboration run to bolster global immuno-oncology footprint, says GlobalData   The need to develop novel innovative cancer drugs at affordable prices is forcing large pharmaceutical firms to collaborate with biotech companies and academic institutions. Japan-based Takeda Pharmaceuticals too is focusing on strategic collaborations to bolster its global immuno-oncology (IO) footprint, says GlobalData, a leading data and analytics company.    In January 2021, Takeda entered a broad strategic collaboration with KSQ Therapeutics to research, develop and commercialize novel im...

Surge Of Bio/Pharma Special Purpose Mergers And Acquisitions Should Be Viewed With Skepticism, Says GlobalData Date 04/02/2021 There has been a boom in bio/pharma special purpose acquisition companies (SPAC) deals in recent years. Last year seems to be no different as SPAC deals continue to provide an alternative way for companies to go public without needing a traditional initial public offering (IPO). However, the long-term success of SPAC acquisition targets in generating revenue remains to be seen, says GlobalData, a leading data and analytics company. GlobalData’s research reveals...

Over a six year period, the Pfizer-BioNTech COVID-19 vaccine is expected to lead inoculation sales, generating $30 billion.

This website uses cookies to enable, optimise and analyse site operations, as well as to provide personalised content and allow you to connect to social media. By clicking "I agree" you consent to the use of cookies for non-essential functions and the related processing of personal data. You can adjust your cookie and associated data processing preferences at any time via our "Cookie Settings". Please view our Cookie Policy to learn more about the use of cookies on our website. Manage your cookiesI agree Cookie Settings Cookie Settings This website uses cookies to improve your experience whil...

GlobalData reveals role of Japan’s immunology market in branded digital marketing space GlobalData reveals role of Japan’s immunology market in branded digital marketing space 15 December 2020 | Analysis Photo Credit: GlobalData The Japanese immunology market is highly competitive with many innovator products available for rheumatoid arthritis (RA), psoriasis (PsO), psoriatic arthritis (PsA), inflammatory bowel disease (IBD) comprising ulcerative colitis (UC) and Crohn’s disease (CD), and ankylosing spondylitis (AS) indications. Across these indications, the branded support a...